Immunochemistry Diagnostic Devices And Equipment Market Segments, Analysis, Overview, Outlook Report 2024-2033

The new report published by The Business Research Company, titled Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the immunochemistry diagnostic devices and equipment market size has grown strongly in recent years. It will grow from $17.84 billion in 2023 to $19.26 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The immunochemistry diagnostic devices and equipment market size is expected to see strong growth in the next few years. It will grow to $25.75 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2547&type=smp

Rising Disease Incidence Rates Propel Immunochemistry Diagnostic Market Growth
An increase in the incidence of target diseases is a major driver for the immunochemistry diagnostic devices and equipment market. The incidence rate of diseases such as viral infections, cardiovascular diseases, cancer, or hormonal disorders is increasing worldwide, mainly due to poor lifestyle choices. For example, according to the American Heart Association, cardiovascular disease is the leading global cause of death, accounting for over 17.6 million deaths per year. This number is expected to grow to over 23.6 million by 2030.

Investments In Automation Transforming Immunochemistry Diagnostic Devices Market
Companies in the immunochemistry diagnostic devices and equipment market are increasingly investing in automated immunoassay systems. This is mainly because automation has led to an increase in the capabilities of diagnostic devices in testing higher volumes of patient specimens. In addition, the development of various integrated clinical chemistry systems has immensely improved the efficiency of the analytical phase of clinical chemistry laboratory testing and led to further automation. For example, ichroma-50 is an automatic immunoassay analyzer of Boditech Med Inc. that measures the concentration of the targeted analyte in body fluids such as blood, urine, and other samples in a few minutes and reduces the labor cost and human error in the process.

The immunochemistry diagnostic devices and equipment market covered in this report is segmented -

1) By Product Type: Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables
2) By Consumables: Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables
3) By Application: Endocrinology, Oncology, Cardiology, Therapeutic Drug Development & Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications
4) By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users

Segments Covered: Analyzers: Chemiluminescence Immunoassay (CLIA) Analyzers, Immuno Fluorescence (IFA) Analyzers, Enzyme Immunoassay (EIA) Analyzers, Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescent Assay (ELFA) Systems, Multiplexed Assay Systems, Automated Stainers, Semi-Automated Stainers

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=2547&type=discount

Major companies operating in the immunochemistry diagnostic devices and equipment market include Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, Diamond Diagnostics Inc., Dynex Technologies Inc., Grifols S.A., Hycor Biomedical LLC, Immunodiagnostic Systems, Inova Diagnostics, LabCorp, Mindray Medical International Limited, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories, Sysmex Corporation, ThermoFisher Scientific Inc., Tosoh Bioscience, Danaher Corporation, Johnson & Johnson, Boditech Med Inc., Beckman Coulter Inc., Bio-Rad Laboratories, bioMérieux Clinical Diagnostics, Carolina Liquid Chemistries Corporate, DiaSorin Inc., Agilent Technologies Inc., Merck KGAA, Eagle Biosciences Inc., Biocare Medical LLC, Elabscience Biotechnology Inc., Bio-Genex Laboratories Inc., Diagnostic Biosystem, Histo-Line Laboratories, Rockland Immunochemicals Inc., Abcam plc, Becton Dickinson & Company, Cell Signaling Technology Inc., ImmunoChemistry Technologies LLC, Genemed Biotechnologies Inc., Miltenyi Biotec GmbH, PerkinElmer Inc., Takara Bio. Inc, Immucor Inc., Quidel Corporation

Contents of the report:
1. Executive Summary
2. Immunochemistry Diagnostic Devices And Equipment Market Report Structure
3. Immunochemistry Diagnostic Devices And Equipment Market Trends And Strategies
4. Immunochemistry Diagnostic Devices And Equipment Market - Macro Economic Scenario
5. Immunochemistry Diagnostic Devices And Equipment Market Size And Growth
…..
27. Immunochemistry Diagnostic Devices And Equipment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/immunochemistry-diagnostic-devices-and-equipment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.